Search results for "1]"

showing 10 items of 266 documents

CCDC 1053886: Experimental Crystal Structure Determination

2016

Related Article: Oana Moncea, Maria A. Gunawan, Didier Poinsot, Hélène Cattey, Jonathan Becker, Raisa I. Yurchenko, Ekaterina D. Butova, Heike Hausmann, Marina Šekutor, Andrey A. Fokin, Jean-Cyrille Hierso, Peter R. Schreiner|2016|J.Org.Chem.|81|8759|doi:10.1021/acs.joc.6b01219

Space GroupCrystallographyCrystal Systempentacyclo[7.3.1.1412.027.0611]tetradecane-49-diylbis(phosphonic dichloride)Crystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 1054569: Experimental Crystal Structure Determination

2016

Space GroupCrystallographyCrystal Systemtribenzyl(9-hydroxypentacyclo[7.3.1.1412.027.0611]tetradec-4-yl)phosphonium bromideCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 165234: Experimental Crystal Structure Determination

2002

Related Article: A.Perjessy, P.Meyer, W.-D.Rudorf, D.Loos, E.Kolehmainen, K.Laihia, M.Nissinen, J.Koivisto, R.Kauppinen|2001|J.Phys.Org.Chem.|14|811|doi:10.1002/poc.436

Space GroupCrystallographyEthyl 3-(4-bromophenyl)carbamoyl-23-diazabicyclo[2.2.1]hept-5-ene-2-carboxylateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 1555957: Experimental Crystal Structure Determination

2017

Related Article: Disha Mungalpara, Arto Valkonen, Kari Rissanen, Stefan Kubik|2017|Chemical Science|8|6005|doi:10.1039/C7SC02700A

Space GroupCrystallographybis(tetra-n-butylammonium) dihydrogen diphosphate 6183042-tetramethyl-345815161720272829323940414449515355-icosa-azanonacyclo[43.3.1.125.1913.11417.12125.12629.13337.13841]hexapentaconta-1(49)2(56)39(55)101214(54)1521(53)222426(52)2733(51)343638(50)394547-icosaene-7193143-tetrone dimethyl sulfoxide unknown solvate hydrateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 782271: Experimental Crystal Structure Determination

2011

Related Article: M.Bodensteiner, M.Dusek, M.M.Kubicki, M.Pronold, M.Scheer, J.Wachter, M.Zabel|2010|Eur.J.Inorg.Chem.||5298|doi:10.1002/ejic.201000796

Space GroupCrystallographycatena-((mu~3~-selenophosphido)-(mu~2~-selenophosphido)-bis(mu~2~-iodo)-(mu~2~-selenido)-(mu~2~-267-triselena-1345-tetraphosphabicyclo[2.2.1]heptane)-bis(eta^5^-pentamethylcyclopentadienyl)-di-copper-di-molybdenum acetonitrile dichloromethane solvate)Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 1026387: Experimental Crystal Structure Determination

2014

Related Article: Artur J. Moro, Bertrand Rome, Elisabet Aguiló, Julià Arcau, Rakesh Puttreddy, Kari Rissanen, João Carlos Lima, Laura Rodríguez|2015|Org.Biomol.Chem.|13|2026|doi:10.1039/C4OB02077D

Space GroupCrystallographycatena-(tris(7-(Prop-2-yn-1-yloxy)-2H-chromen-2-one)-tris(11'-(137-triaza-5-phosphabicyclo[3.3.1]nonane-37-diyl)diethanone)-tri-gold dichloromethane solvate)Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 1553257: Experimental Crystal Structure Determination

2017

Related Article: Matteo Savastano, Paloma Arranz-Mascaros, ́Carla Bazzicalupi, Maria Paz Clares, Maria Luz Godino-Salido, Lluis Guijarro, Maria Dolores Gutierrez-Valero, ́Antonio Bianchi, Enrique García-España, Rafael Lopez-Garzon|2017|ACS Omega|2|3868|doi:10.1021/acsomega.7b00736

Space GroupCrystallographycatena-[(mu-6-amino-3-methyl-5-nitroso-2-({2-[36915-tetraazabicyclo[9.3.1]pentadeca-1(15)1113-trien-6-yl]ethyl}amino)pyrimidin-4(3H)-one)-copper(ii) diperchlorate]Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 1433633: Experimental Crystal Structure Determination

2015

Related Article: G. Hernández, S. Bernès, O. Portillo, A. Ruíz, G.E. Moreno, R. Gutiérrez|2015|Acta Crystallogr.,Sect.E:Cryst.Commun.|71|1462|doi:10.1107/S2056989015020368

Space GroupCrystallographydichloro-(1-(pyridin-2-yl)-N-(266-trimethylbicyclo[3.1.1]hept-3-yl)methanimine)-mercuryCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

CCDC 938080: Experimental Crystal Structure Determination

2013

Related Article: Igor O. Koshevoy, Antti J. Karttunen, Ilya S. Kritchenkou, Dmitrii V. Krupenya, Stanislav I. Selivanov, Alexei S. Melnikov, Sergey P. Tunik, Matti Haukka, and Tapani A. Pakkanen|2013|Inorg.Chem.|52|3663|doi:10.1021/ic302105a

Space GroupCrystallographytetrakis(mu~2~-2-(2-hydroxy-177-trimethylbicyclo[2.2.1]hept-2-yl)ethynyl)-bis(mu~2~-eta^2^-2-(2-hydroxy-177-trimethylbicyclo[2.2.1]hept-2-yl)ethynyl)-tris(mu~2~-14-bis(diphenylphosphino)butane)-hexa-gold-di-silver hexakis(mu~2~-eta^2^-2-(2-hydroxy-177-trimethylbicyclo[2.2.1]hept-2-yl)ethynyl)-tris(mu~2~-14-bis(diphenylphosphino)butane)-hexa-gold-di-silver tetraperchlorate dichloromethane diethyl ether unknown solvateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates

researchProduct

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

2013

Journal article TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of multiple cancers. Using the Illumina custom genotyping array iCOGs, we analyzed ~480 SNPs at the TERT locus in breast (n = 103,991), ovarian (n = 39,774) and BRCA1 mutation carrier (n = 11,705) cancer cases and controls. Leukocyte telomere measurements were also available for 53,724 participants. Most associations cluster into three independent peaks. The minor allele at the peak 1 SNP rs2736108 associates with longer telomeres (P = 5.8 × 10!-7), lower risks for estrogen receptor (ER)-negative (P = 1.0 × 10!-8) and BRCA1 mutation carrier (P = 1.1 × 10!-5) breast cancers and altered promot…

TelomeraseMessengerCàncer d'ovariEstrogen receptorAetiology screening and detection [ONCOL 5]0302 clinical medicineBreast cancerRisk FactorsAlternative Splicing; Biomarkers Tumor; Breast Neoplasms; Case-Control Studies; Chromatin; DNA Methylation; Female; Gene Expression Profiling; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Luciferases; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Polymorphism Single Nucleotide; RNA Messenger; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Telomerase; Telomere; GeneticsGenotypeBUCCAL CELLSLuciferasesTelomeraseOligonucleotide Array Sequence AnalysisOvarian Neoplasms0303 health sciencesTumorTelòmerReverse Transcriptase Polymerase Chain ReactionGENETIC-VARIATIONCOMMON VARIANTSSingle Nucleotidetert-clptm1l locus; genome-wide association; genetic-variation; susceptibility loci; buccal cells; fibroblasts; common variants; carcinoma; reverse-transcriptase htert; metaanalysisTelomereAetiology screening and detection Immune Regulation [ONCOL 5]Chromatin3. Good healthTumor Markers Biological030220 oncology & carcinogenesisFemaleFIBROBLASTSGenotypeSUSCEPTIBILITY LOCICARCINOMASingle-nucleotide polymorphismBreast NeoplasmsBiologyReal-Time Polymerase Chain ReactionPolymorphism Single NucleotideArticleCàncer de mama03 medical and health sciencesBreast cancerSDG 3 - Good Health and Well-beingTranslational research [ONCOL 3]Ovarian cancermedicineGeneticsBiomarkers TumorHumansGenetic Predisposition to DiseaseRNA MessengerPolymorphismAlleleGENOME-WIDE ASSOCIATIONMETAANALYSIS030304 developmental biologyMolecular epidemiology Aetiology screening and detection [NCEBP 1]Breast cancer susceptibilityHereditary cancer and cancer-related syndromes [ONCOL 1]Translational research Genomic disorders and inherited multi-system disorders [ONCOL 3]Gene Expression ProfilingDNA Methylationmedicine.diseaseMolecular biologyTERT-CLPTM1L LOCUSTelomereMinor allele frequencyAlternative SplicingGenetic LociCase-Control StudiesRNABiomarkersREVERSE-TRANSCRIPTASE HTERTGenome-Wide Association StudyNature genetics

researchProduct